Immunological Response to Parenteral Vaccination with Recombinant Hepatitis B Virus Surface Antigen Virus-Like Particles Expressing Helicobacter pylori KatA Epitopes in a Murine H. pylori Challenge Model

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Clinical and Vaccine Immunology

• Publication date

  2011-12-28

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/CVI.05295-11PMID 22205658PMCID PMC3272931
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mechanism of action of licensed vaccine adjuvants.

  2009cited by this paper
• Antibody-Mediated Protection against Infection with Helicobacter pylori in a Suckling Mouse Model of Passive Immunity

  2009cited by this paper
• Chimeric virus-like particles for the delivery of an inserted conserved influenza A-specific CTL epitope.

  2009cited by this paper
• Improved cell mediated immune responses after successful re-vaccination of non-responders to the hepatitis B virus surface antigen (HBsAg) vaccine using the combined hepatitis A and B vaccine.

  2008cited by this paper
• Advanced Antigen Delivery of Murine Survivin: Chimeric Virus-Like Particles in Cancer Vaccine Research

  2007cited by this paper
• Optimisation of secretion of recombinant HBsAg virus-like particles: Impact on the development of HIV-1/HBV bivalent vaccines.

  2007cited by this paper
• The impact of a new universal infant and school-based adolescent hepatitis B vaccination program in Australia.

  2007cited by this paper
• Epidemiology of Helicobacter pylori infection.

  2007cited by this paper
• Immunizations with Chimeric Hepatitis B Virus-Like Particles to Induce Potential Anti-Hepatitis C Virus Neutralizing Antibodies

  2007cited by this paper
• Comparison of 7‐day and 14‐day Proton Pump Inhibitor‐Containing Triple Therapy for Helicobacter pylori Eradication: Neither Treatment Duration Provides Acceptable Eradication Rate in Korea

  2007cited by this paper
• Helicobacter pylori lipopolysaccharide promotes a Th1 type immune response in immunized mice.

  2006influential reference
• Hepatitis B Surface Antigen Vector Delivers Protective Cytotoxic T-Lymphocyte Responses to Disease-Relevant Foreign Epitopes

  2006cited by this paper
• Hepatitis B Virus Particle Formation in the Absence of Pregenomic RNA and Reverse Transcriptase

  2006cited by this paper
• Pathogenesis of Helicobacter pylori Infection

  2006cited by this paper
• Novel human polysaccharide adjuvants with dual Th1 and Th2 potentiating activity.

  2006cited by this paper
• Vaccination as a Method of Preventing Helicobacter pylori–Associated Gastric Cancer

  2005cited by this paper
• Treatment of Helicobacter pylori

  2005cited by this paper
• Hepatitis B small surface antigen particles are octahedral.

  2005cited by this paper
• The humoral immuneresponse to Helicobacter pylori infection in children with gastrointestinal symptoms.

  2005cited by this paper
• Intestinal Helminthiasis in Colombian Children Promotes a Th2 Response to Helicobacter pylori: Possible Implications for Gastric Carcinogenesis

  2005cited by this paper
• Epidemiology of Helicobacter pylori Infection

  2004cited by this paper
• Vaccine adjuvants: Current state and future trends

  2004cited by this paper
• H pylori antibiotic resistance: prevalence, importance, and advances in testing

  2004cited by this paper
• Abnormal Gastroesophageal Flap Valve is Highly Associated with Endoscopic Reflux Esophagitis after Helicobacter pylori Eradication

  2004cited by this paper
• Catalase (KatA) and KatA-associated protein (KapA) are essential to persistent colonization in the Helicobacter pylori SS1 mouse model.

  2003cited by this paper
• Vaccine-Induced Protection against Helicobacter pylori in Mice Lacking Both Antibodies and Interleukin-4

  2003cited by this paper
• Efficacy of triple therapy comprising rabeprazole, amoxicillin and metronidazole for second‐line Helicobacter pylori eradication in Japan, and the influence of metronidazole resistance

  2003cited by this paper
• Immunogenicity of recombinant HBsAg/HCV particles in mice pre-immunised with hepatitis B virus-specific vaccine.

  2003cited by this paper
• Resistance to hydrogen peroxide in Helicobacter pylori: role of catalase (KatA) and Fur, and functional analysis of a novel gene product designated 'KatA-associated protein', KapA (HP0874).

  2002cited by this paper
• Pathogenesis of Helicobacter pylori infection

  2002influential reference
• Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti-inflammatory drugs: a randomised trial.

  2002cited by this paper
• Helicobacter pylori-specific immunoglobulin synthesis in gnotobiotic piglets: evidence for the induction of mucosal immunity in the stomach.

  2002cited by this paper
• Localization of antigen‐presenting cells in Helicobacter pylori‐infected gastric mucosa

  2002cited by this paper
• Antigenicity and Immunogenicity of Novel Chimeric Hepatitis B Surface Antigen Particles with Exposed Hepatitis C Virus Epitopes

  2001cited by this paper
• The design of vaccines against Helicobacter pylori and their development.

  2001cited by this paper
• Induction of chemokine and cytokine responses by Helicobacter pylori in human stomach explants.

  2001influential reference
• Distinct Mechanism of Helicobacter pylori-mediated NF-κB Activation between Gastric Cancer Cells and Monocytic Cells*

  2001cited by this paper
• The importance of interleukin 1β inHelicobacter pylori associated disease

  2001cited by this paper
• The importance of interleukin 1beta in Helicobacter pylori associated disease.

  2001cited by this paper
• Pattern of primary resistance of Helicobacter pylori to metronidazole or clarithromycin in the United States.

  2001cited by this paper
• Circulating T‐Cell Response to Helicobacter pylori Infection in Chronic Gastritis

  2000influential reference
• Analysis of rdxA and Involvement of Additional Genes Encoding NAD(P)H Flavin Oxidoreductase (FrxA) and Ferredoxin-Like Protein (FdxB) in Metronidazole Resistance of Helicobacter pylori

  2000cited by this paper
• CXC chemokines Gro(alpha)/IL-8 and IP-10/MIG in Helicobacter pylori gastritis.

  2000cited by this paper
• Interleukin-1 polymorphisms associated with increased risk of gastric cancer

  2000cited by this paper
• CXC chemokines Groα/IL‐8 and IP‐10/MIG in Helicobacter pylori gastritis

  2000cited by this paper
• Immunogenicity of a combined hepatitis A and B vaccine in healthy young adults.

  2000cited by this paper
• Catalase immunization from Pseudomonas aeruginosa enhances bacterial clearance in the rat lung.

  2000cited by this paper
• Suppressive effects of DNA vaccines encoding heat shock protein on Helicobacter pylori-induced gastritis in mice.

  2000cited by this paper
• Parenteral Adjuvant Activities of Escherichia coli Heat-Labile Toxin and Its B Subunit for Immunization of Mice against Gastric Helicobacter pyloriInfection

  2000cited by this paper
• Helicobacter pylori-Induced Mucosal Inflammation Is Th1 Mediated and Exacerbated in IL-4, But Not IFN-γ, Gene-Deficient Mice1

  2000cited by this paper
• Concurrent enteric helminth infection modulates inflammation and gastric immune responses and reduces helicobacter-induced gastric atrophy

  2000cited by this paper
• Characterization of the T‐ and B‐cell immune response to a new recombinant pre‐S1, pre‐S2 and SHBs antigen containing hepatitis B vaccine (Hepagene™); evidence for superior anti‐SHBs antibody induction in responder mice

  1998cited by this paper
• A low rate of reinfection following effective therapy against Helicobacter pylori in a developing nation (China).

  1998cited by this paper
• Immunization of Mice with Urease Vaccine Affords Protection against Helicobacter pylori Infection in the Absence of Antibodies and Is Mediated by MHC Class II–restricted Responses

  1998cited by this paper
• Systemic immunization with urease protects mice against Helicobacter pylori infection.

  1998cited by this paper
• Core particles of hepatitis B virus as carrier for foreign epitopes.

  1998cited by this paper
• vaccine in The Netherlands . persons vaccinated with inactivated poliovirus Poliovirus-specific immunoglobulin A in

  1997cited by this paper
• Copyright © 1997, American Society for Microbiology Catalase, a Novel Antigen for Helicobacter pylori Vaccination

  1997cited by this paper
• Virus-Like Particles Induce MHC Class I-Restricted T-Cell Responses

  1996cited by this paper
• Cloning and genetic characterization of Helicobacter pylori catalase and construction of a catalase-deficient mutant strain

  1996cited by this paper
• Virus-like particles induce MHC class I-restricted T-cell responses. Lessons learned from the hepatitis B small surface antigen.

  1996cited by this paper
• Deletional switch recombination occurs in interleukin-4-induced isotype switching to IgE expression by human B cells.

  1991influential reference
• Mucosal tumour necrosis factor alpha and interleukin-6 in patients with Helicobacter pylori associated gastritis.

  1991cited by this paper
• Prostaglandin E2 promotes IL-4-induced IgE and IgG1 synthesis.

  1990influential reference
• Structural factors modulate the activity of antigenic poliovirus sequences expressed on hybrid hepatitis B surface antigen particles

  1990cited by this paper
• Cross-protection of infant mice against intestinal colonisation by Campylobacter jejuni: importance of heat-labile serotyping (Lior) antigens.

  1988cited by this paper
• Insertions in the hepatitis B surface antigen. Effect on assembly and secretion of 22-nm particles from mammalian cells.

  1987cited by this paper
• Clinical evaluation of a recombinant hepatitis B vaccine.

  1984cited by this paper

• VLP (Virus-Like Particles) Vaccines - Current Knowledge and Future Directions

  2025cites this paper
• Affinity-purified sHBsAg-based virus-like particles as a platform for foreign mRNA binding.

  2025cites this paper
• Advances and Challenges in Helicobacter pylori Subunit Vaccine Development: Antigen Candidates and Immunization Strategies.

  2025cites this paper
• Identifying Key Drivers of Efficient B Cell Responses: On the Role of T Help, Antigen-Organization, and Toll-like Receptor Stimulation for Generating a Neutralizing Anti-Dengue Virus Response

  2024cites this paper
• An intranasal influenza virus vector vaccine protects against Helicobacter pylori in mice

  2024cites this paper
• Chimeric hepatitis B surface antigen virus-like particles expressing the strep A epitope p*17 elicit a humoral immune response in mice

  2024influential citation
• Virus-like Particle Vaccines and Platforms for Vaccine Development

  2023cites this paper
• Reactive oxygen species and gastric carcinogenesis: The complex interaction between Helicobacter pylori and host

  2023cites this paper
• Immunogenicity of Wild Type and Mutant Hepatitis B Surface Antigen Virus-like Particles (VLPs) in Mice with Pre-Existing Immunity against the Wild Type Vector

  2023cites this paper
• Hepatitis B Virus (HBV) Subviral Particles as Protective Vaccines and Vaccine Platforms

  2020cites this paper
• Specific Antibodies Induced by Immunization with Hepatitis B Virus-Like Particles Carrying Hepatitis C Virus Envelope Glycoprotein 2 Epitopes Show Differential Neutralization Efficiency

  2020cites this paper
• Potential antigen candidates for subunit vaccine development against Helicobacter pylori infection

  2019cites this paper
• Potent effect of KISS1-54 DNA vaccine compared with KISS1-10 DNA vaccine in inhibiting the fertility of female rats.

  2018cites this paper
• The study of H. pylori putative candidate factors for single- and multi-component vaccine development

  2017cites this paper
• Biodefense and Special Pathogen Vaccines

  2017cites this paper
• Kisspeptin recombinant oral vaccine: A master gene vaccine inhibiting the reproductive physiology and behavior of ram lambs.

  2017cites this paper
• High Levels of IgA Antibodies to Helicobacter Pylori among Omani Women during Pregnancy and after Delivery.

  2016cites this paper
• Hepatitis B Surface Antigen S Gene is an Effective Carrier Molecule for Developing GnRH DNA Immunocastration Vaccine in Mice.

  2016cites this paper
• Why Donʼt We Have a Vaccine Against……….? Part 3. Bacteria, Too

  2016cites this paper
• Immunogenicity of Leishmania-derived hepatitis B small surface antigen particles exposing highly conserved E2 epitope of hepatitis C virus

  2016cites this paper
• KISS1 can be used as a novel target for developing a DNA immunocastration vaccine in ram lambs.

  2015cites this paper
• Immunological responses associated with the use of a putative dual vaccine against Hepatitis B Virus and Streptococcus pneumoniae

  2015cites this paper
• Group A Streptococcal Peptides expressed in HBsAg-S VLPs as a vaccine candidate

  2014influential citation
• Hepatitis B virus surface antigen as delivery vector can enhance Chlamydia trachomatis MOMP multi-epitope immune response in mice

  2014cites this paper
• Key host-pathogen interactions for designing novel interventions against Helicobacter pylori.

  2013cites this paper
• 41 – Biodefense and special pathogen vaccines

  2013cites this paper
• Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures

  2013cites this paper
• Neglected infectious diseases in Aboriginal communities: Haemophilus influenzae serotype a and Helicobacter pylori.

  2012cites this paper